RecruitingNCT06575842
Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
Sponsor
University of Colorado, Denver
Enrollment
120 participants
Start Date
Aug 21, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.
Eligibility
Min Age: 2 YearsMax Age: 26 Years
Plain Language Summary
Simplified for easier understanding
This study is checking whether continuous glucose monitors (small sensors worn on the body) give accurate blood sugar readings in young people with type 1 diabetes who are having surgery or another medical procedure. Accurate readings during surgery are important for safe care.
**You may be eligible if...**
- You are between 2 and 26 years old
- You have type 1 diabetes and are on insulin
- You are already wearing a continuous glucose monitor
- You are scheduled for surgery or a procedure that requires close blood sugar monitoring
**You may NOT be eligible if...**
- You do not already wear a continuous glucose monitor
- You or your parent/guardian are unable to provide consent
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06575842
Related Trials
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
NCT076383451 location
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
NCT075608131 location
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
NCT0706157411 locations
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
NCT058226094 locations
French Prospective Multicentric Study in Real World
NCT0703994224 locations